326 related articles for article (PubMed ID: 35530346)
1. Current and Emerging Prognostic Biomarkers in Endometrial Cancer.
Njoku K; Barr CE; Crosbie EJ
Front Oncol; 2022; 12():890908. PubMed ID: 35530346
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis.
Coll-de la Rubia E; Martinez-Garcia E; Dittmar G; Gil-Moreno A; Cabrera S; Colas E
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32560580
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review.
Romano A; Rižner TL; Werner HMJ; Semczuk A; Lowy C; Schröder C; Griesbeck A; Adamski J; Fishman D; Tokarz J
Front Oncol; 2023; 13():1120178. PubMed ID: 37091170
[TBL] [Abstract][Full Text] [Related]
5. The role of biomarkers in endometrial cancer and hyperplasia: a literature review.
Hutt S; Tailor A; Ellis P; Michael A; Butler-Manuel S; Chatterjee J
Acta Oncol; 2019 Mar; 58(3):342-352. PubMed ID: 30614360
[TBL] [Abstract][Full Text] [Related]
6. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
7. Genomics and splicing events of type II endometrial cancers in the black population: racial disparity, socioeconomic and geographical differences.
Francies FZ; Marima R; Hull R; Molefi T; Dlamini Z
Am J Cancer Res; 2020; 10(10):3061-3082. PubMed ID: 33163258
[TBL] [Abstract][Full Text] [Related]
8. Identification of autophagy-related long non-coding RNAs in endometrial cancer via comprehensive bioinformatics analysis.
Liu H; Cheng Y
BMC Womens Health; 2022 Mar; 22(1):85. PubMed ID: 35321716
[TBL] [Abstract][Full Text] [Related]
9. Prognostic molecular biomarkers in endometrial cancer: A review.
Hernández JE; González-Montiel A; Allos-Villalva JCC; Cantú D; Barquet S; Olivares-Mundo A; Herrera LA; Prada D
J Cancer Res Ther (Manch); 2019 Dec; 7(3):17-28. PubMed ID: 34322276
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment risk assessment of women with endometrial cancer: differences in outcomes of molecular and clinical classifications in the Slovenian patient cohort.
Knez J; Sobocan M; Belak U; Kavalar R; Zupin M; Büdefeld T; Potocnik U; Takac I
Radiol Oncol; 2021 Sep; 56(1):76-82. PubMed ID: 34529911
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis.
Njoku K; Ramchander NC; Wan YL; Barr CE; Crosbie EJ
Gynecol Oncol; 2022 Jan; 164(1):146-153. PubMed ID: 34802721
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer.
Njoku K; Sutton CJ; Whetton AD; Crosbie EJ
Metabolites; 2020 Jul; 10(8):. PubMed ID: 32751940
[TBL] [Abstract][Full Text] [Related]
14. [Circulating tumor DNA assessment for gynaecological cancers management].
Mari R; Lambaudie É; Provansal M; Sabatier R
Bull Cancer; 2019 Mar; 106(3):237-252. PubMed ID: 30765097
[TBL] [Abstract][Full Text] [Related]
15. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
Kommoss S; McConechy MK; Kommoss F; Leung S; Bunz A; Magrill J; Britton H; Kommoss F; Grevenkamp F; Karnezis A; Yang W; Lum A; Krämer B; Taran F; Staebler A; Lax S; Brucker SY; Huntsman DG; Gilks CB; McAlpine JN; Talhouk A
Ann Oncol; 2018 May; 29(5):1180-1188. PubMed ID: 29432521
[TBL] [Abstract][Full Text] [Related]
16. An Integrated Autophagy-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer: A Bioinformatics-Based Approach.
Wang Z; Zhang J; Liu Y; Zhao R; Zhou X; Wang H
Biomed Res Int; 2020; 2020():5717498. PubMed ID: 33381557
[TBL] [Abstract][Full Text] [Related]
17. Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group.
Zannoni GF; Bragantini E; Castiglione F; Fassan M; Troncone G; Inzani F; Pesci A; Santoro A; Fraggetta F
Front Oncol; 2022; 12():805613. PubMed ID: 35463299
[TBL] [Abstract][Full Text] [Related]
18. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.
Albertí-Valls M; Megino-Luque C; Macià A; Gatius S; Matias-Guiu X; Eritja N
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201612
[TBL] [Abstract][Full Text] [Related]
20. Innovative Follow-up Strategies for Endometrial Cancer.
Collins A; Taylor A; Guttery DS; Moss EL
Clin Oncol (R Coll Radiol); 2021 Sep; 33(9):e383-e392. PubMed ID: 34172343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
